Division of Hematology, Department of Internal Medicine, School of Medicine of Ribeirão Preto, University of São Paulo, Av. Bandeirantes, 3900, 14049-900, Ribeirão Preto, SP, Brazil.
Med Oncol. 2012 Dec;29(4):2332-6. doi: 10.1007/s12032-011-0142-3. Epub 2011 Dec 31.
Chronic myelogenous leukemia (CML) is a common myeloproliferative disease that is characterized by the clonal expansion of marrow stem cells, and is associated with the Philadelphia chromosome. As the disease progresses, additional chromosome abnormalities may arise. The prognostic impact of secondary chromosomal abnormalities in CML is complex, heterogeneous, and sometimes related to previous treatment. Here, we describe a CML patient in lymphoid blast crisis associated with a new chromosomal abnormality identified, dic(7;12)(p12.21;p12.2) and i(12)(q10) using classical cytogenetics and spectral karyotype analysis. To the best of our knowledge, this is the first report of t(7;12)(p11.1;q11.1) and i(12)(q10) in a CML patient with lymphoid evolution.
慢性髓性白血病(CML)是一种常见的骨髓增生性疾病,其特征是骨髓干细胞的克隆性扩张,并与费城染色体有关。随着疾病的进展,可能会出现其他染色体异常。CML 中继发性染色体异常的预后影响是复杂的、异质的,有时与先前的治疗有关。在这里,我们描述了一例伴有新染色体异常的 CML 患者,即淋巴母细胞危象,使用经典细胞遗传学和光谱核型分析发现dic(7;12)(p12.21;p12.2)和i(12)(q10)。据我们所知,这是首例报道 t(7;12)(p11.1;q11.1)和 i(12)(q10)在 CML 患者中发生淋巴样演变。